Cargando…
Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug
BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885879/ https://www.ncbi.nlm.nih.gov/pubmed/36726738 http://dx.doi.org/10.2147/DDDT.S377686 |
_version_ | 1784880020128268288 |
---|---|
author | Bashir, Muhammad Anwar Khan, Amjad Shah, Sayyed Ibrahim Ullah, Majeed Khuda, Fazli Abbas, Muhammad Goh, Khang Wen Ming, Long Chiau |
author_facet | Bashir, Muhammad Anwar Khan, Amjad Shah, Sayyed Ibrahim Ullah, Majeed Khuda, Fazli Abbas, Muhammad Goh, Khang Wen Ming, Long Chiau |
author_sort | Bashir, Muhammad Anwar |
collection | PubMed |
description | BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. METHODS: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. RESULTS: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%–101%). The crushing strength of all formulations was in the range of 58–96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. CONCLUSION: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin. |
format | Online Article Text |
id | pubmed-9885879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98858792023-01-31 Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug Bashir, Muhammad Anwar Khan, Amjad Shah, Sayyed Ibrahim Ullah, Majeed Khuda, Fazli Abbas, Muhammad Goh, Khang Wen Ming, Long Chiau Drug Des Devel Ther Original Research BACKGROUND: Self-emulsifying drug-delivery systems (SEDDSs) are designed to improve the oral bioavailability of poorly water-soluble drugs. This study aimed at formulating and characterization of SEDDS-based tablets for simvastatin using castor and olive oils as solvents and Tween 60 as surfactant. METHODS: The liquids were adsorbed on microcrystalline cellulose, and all developed formulations were compressed using 10.5 mm shallow concave round punches. RESULTS: The resulting tablets were evaluated for different quality-control parameters at pre- and postcompression levels. Simvastatin showed better solubility in a mixture of oils and Tween 60 (10:1). All the developed formulations showed lower self-emulsification time (˂200 seconds) and higher cloud point (˃60°C). They were free of physical defects and had drug content within the acceptable range (98.5%–101%). The crushing strength of all formulations was in the range of 58–96 N, and the results of the friability test were within the range of USP (≤1). Disintegration time was within the official limits (NMT 15 min), and complete drug release was achieved within 30 min. CONCLUSION: Using commonly available excipients and machinery, SEDDS-based tablets with better dissolution profile and bioavailability can be prepared by direct compression. These S-SEDDSs could be a better alternative to conventional tablets of simvastatin. Dove 2023-01-26 /pmc/articles/PMC9885879/ /pubmed/36726738 http://dx.doi.org/10.2147/DDDT.S377686 Text en © 2023 Bashir et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Bashir, Muhammad Anwar Khan, Amjad Shah, Sayyed Ibrahim Ullah, Majeed Khuda, Fazli Abbas, Muhammad Goh, Khang Wen Ming, Long Chiau Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title | Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title_full | Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title_fullStr | Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title_full_unstemmed | Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title_short | Development and Evaluation of Self-Emulsifying Drug-Delivery System–Based Tablets for Simvastatin, a BCS Class II Drug |
title_sort | development and evaluation of self-emulsifying drug-delivery system–based tablets for simvastatin, a bcs class ii drug |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885879/ https://www.ncbi.nlm.nih.gov/pubmed/36726738 http://dx.doi.org/10.2147/DDDT.S377686 |
work_keys_str_mv | AT bashirmuhammadanwar developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT khanamjad developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT shahsayyedibrahim developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT ullahmajeed developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT khudafazli developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT abbasmuhammad developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT gohkhangwen developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug AT minglongchiau developmentandevaluationofselfemulsifyingdrugdeliverysystembasedtabletsforsimvastatinabcsclassiidrug |